Value: the fourth hurdle
This article was originally published in Clinica
Executive Summary
In the second article of Clinica's series on demonstrating the value of medical devices, Dr Mark Charny of UK consultancy Translucency discusses why it is necessary to demonstrate value and its implications on market access, as well as how value is perceived between different stakeholders